Lewy bodies in Alzheimer's Disease: A neuropathological review of 145 cases using α-synuclein immunohistochemistry

Brain Pathology

Volumn 10, Issue 3, 2000, Pages 378-384

  Hamilton, Ronald L ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN;

ACCURACY; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; DOWN SYNDROME; FAMILIAL DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEWY BODY; MAJOR CLINICAL STUDY; NEUROPATHOLOGY; TECHNIQUE;

EID: 0033919992     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2000.tb00269.x     Document Type: Article

References (35)

1. Anonymous (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging 18: S1-2
2. Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, Trojanowski JQ, Iwatsubo T (1998) Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 152: 879-884
3. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropath 82: 239-259
4. Braak H, Braak E, Yilmazer D, de Vos RA, Jansen EN, Bohl J (1996) Pattern of brain destruction in Parkinson's and Alzheimer's diseases. J Neural Trans 103: 455-490
5. Dickson DW (1990) Lewy body variant [letter; comment]. Neurology 40: 1147-1150
6. Dickson DW, Crystal H, Mattiace LA, Kress Y, Schwagerl A, Ksiezak-Reding H, Davies P, Yen SH (1989) Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques. Acta Neuropath 78: 572-584
7. Dickson DW, Crystal HA, Mattiace LA, Masur DM, Blau AD, Davies P, Yen SH, Aronson MK (1992) Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 13: 179-189
8. Forstl H, Burns A, Luthert P, Cairns N, Levy R (1993) The Lewy-body variant of Alzheimer's disease. Clinical and pathological findings. Br J Psychia 162: 385-392
9. Galasko D, Hansen LA, Katzman R, Wiederholt W, Masliah E, Terry R, Hill LR, Less in P, Thal LJ (1994) Clinical-neuropathological correlations in Alzheimer's disease and related dementias. Arch Neurol 51: 888-895
10. Gomez-Tortosa E, Newell K, Irizarry MC, Albert M, Growdon JH, Hyman BT (1999) Clinical and quantitative pathologic correlates of dementia with Lewy bodies. Neurology 53: 1284-1291
11. Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, Thal L, Pay MM, Hofstetter R, Klauber M (1990) The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology 40:1-7
12. Hansen LA, Masliah E, Galasko D, Terry RD (1993) Plaque-only Alzheimer disease is usually the Lewy body variant, and vice versa. J Neuropathol Exp Neurol 52: 648-654
13. Hansen LA, Samuel W (1997) Criteria for Alzheimer's disease and the nosology of dementia with Lewy bodies. Neurology 48: 126-132
14. Heyman A, Fillenbaum GG, Gearing M, Mirra SS, Welsh-Bohmer KA, Peterson B, Pieper C (1999) Comparison of Lewy body variant of Alzheimer's disease with pure Alzheimer's disease: Consortium to Establish a Registry for Alzheimer's Disease, Part XIX. Neurology 52: 1839-1844
15. Hughes A, Daniel S, al. e (1993) A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 50: 140-148
16. Ince P, Irving D, McArthur F, Perry R (1991) Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Alzheimer type, of senile demntia of Lewy type, Parkinson's disease and nondemented elderly control patients. J Neurological Sci 142-152
17. Ince PG, McArthur FK, Bjenness E, Torvik A, Candy JM, Edwardson JA (1995) Neuropathological diagnoses in elderly patients in Oslo: Alzheimer's disease, Lewy body disease, vascular lesions. Dementia 6: 162-168
18. Ince PG, Perry EK, Morris CM (1998) Dementia with Lewy bodies. A distinct non-Alzheimer dementia syndrome? Brain Pathol 8: 299-324
19. Jakes R, Crowther R, Lee V-Y, Trojanowski J, Iwatsubo T, Goedert M (1999) Epitope mapping of LB509, a monoclonal antibody against human α-synuclein. Neurosci Letters 269: 13-16
20. Kazee AM, Han LY (1995) Cortical Lewy bodies in Alzheimer's disease. Arch Path Lab Med 119: 448-453
21. Kosaka K, Iseki E, Odawara T, Yamamoto T (1996) Cerebral type of Lewy body disease. Neuropathol 16: 32-35
22. Lennox G, Lowe J, Landon M, Byrne EJ, Mayer RJ, Godwin-Austen RB (1989) Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. J Neurol Neurosurg Psychiat 52: 1236-1247
23. Lindboe CF, Hansen HB (1998) The frequency of Lewy bodies in a consecutive autopsy series. Clin Neuropathol 17: 204-209
24. Lippa CF, Fujiwara H, Mann DM, Giasson B, Baba M, Schmidt ML, Nee LE, B OC, Pollen DA, St. George-Hyslop P, Ghetti B, Nochlin D, Bird TD, Cairns NJ, Lee VM, Iwatsubo T, Trojanowski JQ (1998) Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol 153: 1365-1370
25. Lippa CF, Schmidt ML, Lee VM, Trojanowski JQ (1999) Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease. Ann Neurol 45: 353-357
26. Lopez O, Hamilton R, Becker J, Wisniewski S, Kaufer D, DeKosky S (1998) Clinical features and predictors of progression in patients with Alzheimer's disease and with the Lewy body variant of Alzheimer's disease (abstract). Neurology 50 (suppl 4): A182
27. McKeith IG, Fairbairn AF, Bothwell RA, Moore PB, Ferrier IN, Thompson P, Perry RH (1994) An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology 44: 872-877
28. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47: 1113-1124
29. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E (1984) Clinical diagnosis of Alzheimer's Disease: report of the NINCDS/ADRDA Workgroup under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944
30. Mega MS, Masterman DL, Benson DF, Vinters HV, Tomiyasu U, Craig AH, Foti DJ, Kaufer D, Scharre DW, Fairbanks L, Cummings JL (1996) Dementia with Lewy bodies: reliability and validity of clinical and pathologic criteria. Neurology 47: 1403-1409
31. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-486
32. Olichney JM, Galasko D, Salmon DP, Hofstetter CR, Hansen LA, Katzman R, Thal LJ (1998) Cognitive decline is faster in Lewy body variant than in Alzheimer's disease. Neurology 51: 351-357
33. Rezaie P, Cairns NJ, Chadwick A, Lantos PL (1996) Lewy bodies are located preferentially in limbic areas in diffuse Lewy body disease. Neurosci Letters 212: 111-114
34. Sugiyama H, Hainfellner JA, Yoshimura M, Budka H (1994) Neocortical changes in Parkinson's disease, revisited. Clin Neuropathol 13: 55-59
35. Victoroff J, Mack WJ, Lyness SA, Chui HC (1995) Multicenter clinicopathological correlation in dementia. Am J Psychiat 152: 1476-1484.